Evidence of Inbreeding in Hodgkin Lymphoma.

Evidence of Inbreeding in Hodgkin Lymphoma.

Genome-wide association studies (GWASs) have identified several, mainly co-dominantly acting, single-nucleotide polymorphisms (SNPs) associated with Hodgkin lymphoma (HL). We searched for recessively acting disease loci by performing an analysis of runs of homozygosity (ROH) based on windows of homo...

Full description

Bibliographic Details
Main Authors:	Hauke Thomsen, Miguel Inacio da Silva Filho, Michael Fuchs, Sabine Ponader, Elke Pogge von Strandmann, Lewin Eisele, Stefan Herms, Per Hoffmann, Andreas Engert, Kari Hemminki, Asta Försti
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4849743?pdf=render

Similar Items

THE CHEMOKINE CCL17/TARC AS A BIOMARKER IN HODGKIN LYMPHOMA
by: Maike Sauer, et al.
Published: (2013-08-01)

Hodgkin Lymphoma-Derived Extracellular Vesicles Change the Secretome of Fibroblasts Toward a CAF Phenotype
by: Bastian Dörsam, et al.
Published: (2018-06-01)

Identification of Familial Hodgkin Lymphoma Predisposing Genes Using Whole Genome Sequencing
by: Aayushi Srivastava, et al.
Published: (2020-03-01)

Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility
by: Amit Sud, et al.
Published: (2017-12-01)

The histone deacetylase inhibitor LBH589 (panobinostat) modulates the crosstalk of lymphocytes with Hodgkin lymphoma cell lines.
by: Jan M Klein, et al.
Published: (2013-01-01)

Familial risks between Graves disease and Hashimoto thyroiditis and other autoimmune diseases in the population of Sweden
by: Hauke Thomsen, et al.
Published: (2020-01-01)

Familial associations between autoimmune hepatitis and primary biliary cholangitis and other autoimmune diseases.
by: Hauke Thomsen, et al.
Published: (2020-01-01)

Epidemiology of Amyloidosis and Genetic Pathways to Diagnosis and Typing
by: Kari Hemminki, et al.
Published: (2021-07-01)

Incidence, Mortality and Survival Trends in Breast Cancers Coincident with Introduction of Mammography in the Nordic Countries
by: Kari Hemminki, et al.
Published: (2022-11-01)

Conditional survival in breast cancer up to 10 years in the Nordic countries
by: Frantisek Zitricky, et al.
Published: (2023-09-01)

Incidence and survival in laryngeal and lung cancers in Finland and Sweden through a half century.
by: Anni Koskinen, et al.
Published: (2022-01-01)

Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment
by: Kari Hemminki, et al.
Published: (2022-04-01)

Survival trends in hematological malignancies in the Nordic countries through 50 years
by: Kari Hemminki, et al.
Published: (2022-11-01)

Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden
by: Kari Hemminki, et al.
Published: (2021-11-01)

Incidence, mortality and survival in multiple myeloma compared to other hematopoietic neoplasms in Sweden up to year 2016
by: Kari Hemminki, et al.
Published: (2021-08-01)

Long-Term Periodic and Conditional Survival Trends in Prostate, Testicular, and Penile Cancers in the Nordic Countries, Marking Timing of Improvements
by: Filip Tichanek, et al.
Published: (2023-08-01)

Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of Improvements
by: Frantisek Zitricky, et al.
Published: (2023-08-01)

Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century
by: Filip Tichanek, et al.
Published: (2023-05-01)

Survival in gastric and esophageal cancers in the Nordic countries through a half century
by: Kari Hemminki, et al.
Published: (2023-05-01)

Survival, Incidence, and Mortality Trends in Female Cancers in the Nordic Countries
by: Filip Tichanek, et al.
Published: (2023-01-01)

Long-term survival trends for primary liver and pancreatic cancers in the Nordic countries
by: Kari Hemminki, et al.
Published: (2022-12-01)

Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factor
by: Kari Hemminki, et al.
Published: (2021-05-01)

Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years
by: Kari Hemminki, et al.
Published: (2022-01-01)

Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden.
by: Kari Hemminki, et al.
Published: (2021-01-01)

DNA Repair Gene Polymorphisms and Chromosomal Aberrations in Exposed Populations
by: Yasmeen Niazi, et al.
Published: (2021-06-01)

THERAPY-RELATED MYELOID NEOPLASMS IN PATIENTS TREATED FOR HODGKIN LYMPHOMA
by: Dennis A Eichenauer, et al.
Published: (2011-10-01)

Controversies in the Treatment of Classical Hodgkin Lymphoma
by: Dennis A. Eichenauer, et al.
Published: (2018-10-01)

Survival in common cancers defined by risk and survival of family members
by: Jianguang Ji, et al.
Published: (2011-10-01)

The 'common disease-common variant' hypothesis and familial risks.
by: Kari Hemminki, et al.
Published: (2008-01-01)

Suicide in European Hodgkin Lymphoma Patients
by: Austin I. Kim, et al.
Published: (2019-04-01)

Survival in Colon, Rectal and Small Intestinal Cancers in the Nordic Countries through a Half Century
by: Filip Tichanek, et al.
Published: (2023-02-01)

Are population level familial risks and germline genetics meeting each other?
by: Kari Hemminki, et al.
Published: (2023-03-01)

Origin of B-Cell Neoplasms in Autoimmune Disease.
by: Kari Hemminki, et al.
Published: (2016-01-01)

Consensus pathways implicated in prognosis of colorectal cancer identified through systematic enrichment analysis of gene expression profiling studies.
by: Jesús Lascorz, et al.
Published: (2011-01-01)

Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century
by: Frantisek Zitricky, et al.
Published: (2024-01-01)

Familial Risks and Proportions Describing Population Landscape of Familial Cancer
by: Kari Hemminki, et al.
Published: (2021-08-01)

Prostate cancer survivors: Risk and mortality in second primary cancers
by: Subhayan Chattopadhyay, et al.
Published: (2018-11-01)

Surveillance Bias in Cancer Risk After Unrelated Medical Conditions: Example Urolithiasis
by: Kari Hemminki, et al.
Published: (2017-08-01)

Bladder and upper urinary tract cancers as first and second primary cancers
by: Guoqiao Zheng, et al.
Published: (2021-12-01)

Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis
by: Kari Hemminki, et al.
Published: (2024-04-01)